TerenceWareFriedlanderMD

Assistant Professor, Medicine, University of California, San Francisco, School of

Dr. Friedlander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1825 Fourth St. Sixth Floor
UCSF Medical Center
San Francisco, CA 94158
Phone+1 415-476-4616

University of California (San Francisco)Residency, Internal Medicine, 2003 - 2006
New York University School of MedicineClass of 2003

PubMed

3 citations
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients.
Chloe E. Atreya, Eric A. Collisson, Meyeon Park, James P. Grenert, Spencer C. Behr
Journal of the National Comprehensive Cancer Network. 2020-11-02
278 citations
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, Rick Bangs, Stephen A Boorjian
Journal of the National Comprehensive Cancer Network. 2020-03-01
666 citations
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study
Thomas Powles, Peter H. O'Donnell, Christophe Massard, Hendrik Tobias Arkenau, Terence W. Friedlander
JAMA Oncology. 2017-09-14

Lectures

Additional Immunotherapeutic Options Beyond Anti-PD1/Anti-PD-L1
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Post-ASCO News Alert: Merck’s KEYNOTE-564 Data Heralds Early Adjuvant Keytruda Use in Renal CancerJune 17th, 2021
UCSF Health Cancer Experts Featured at Premier Cancer MeetingJune 4th, 2023